References

Juvenile idiopathic arthritis

10.1038/s41572-021-00332-8 · 2022 · External reference

Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications

10.1136/bmj.k1036 · 2018 · External reference

Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders

10.1136/heartjnl-2015-307838 · 2016 · External reference

Patients with rheumatoid arthritis have an increased risk of incident chronic kidney disease: a systematic review and meta-analysis of cohort studies

10.1007/s11255-019-02346-4 · 2020 · External reference

The relationship between rheumatoid arthritis and diabetes mellitus: a systematic review and meta-analysis

10.1097/xce.0000000000000244 · 2021 · External reference

Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis

10.1136/annrheumdis-2013-205058 · 2015 · External reference

Juvenile idiopathic arthritis and future risk for cardiovascular disease: a multicenter study

10.3109/03009742.2015.1126345 · 2016 · External reference

Comorbidity profiles among adult patients with juvenile idiopathic arthritis: results of a biologic register

2013 · External reference

Arterial properties in adults with long-lasting active juvenile idiopathic arthritis compared to healthy controls

10.1186/s12969-018-0302-5 · 2018 · External reference

Chronic kidney disease

10.1016/s0140-6736(11)60178-5 · 2012 · External reference

The effects of disease-modifying antirheumatic drugs on cardiovascular risk in inflammatory joint diseases: current evidence and uncertainties

10.2147/vhrm.s523939 · 2025 · External reference

Atherosclerotic cardiovascular disease in rheumatoid arthritis: impact of inflammation and antirheumatic treatment

10.15420/ecr.2020.44 · 2021 · External reference

Diabetes-modifying antirheumatic drugs: the roles of DMARDs as glucose-lowering agents

10.3390/medicina58050571 · 2022 · External reference

Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease

10.1016/j.kint.2017.11.025 · 2018 · External reference

Effect of low-dose methotrexate on eGFR and kidney adverse events: a randomized clinical trial

10.1681/asn.2021050598 · 2021 · External reference

International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001

2004 · External reference

Long-term outcomes in juvenile idiopathic arthritis: Eighteen years of follow-up in the population-based nordic juvenile idiopathic arthritis cohort

10.1002/acr.23853 · 2020 · External reference

Long-term outcome in patients with juvenile idiopathic arthritis

10.1002/art.10444 · 2002 · External reference

Disease course, outcome, and predictors of outcome in a population-based juvenile chronic arthritis cohort followed for 17 years

10.3899/jrheum.120602 · 2013 · External reference

Predictors and long-term outcome in Greek adults with juvenile idiopathic arthritis: a 17-year continuous follow-up study

10.1093/rheumatology/kex265 · 2017 · External reference

The autoimmune burden in juvenile idiopathic arthritis

10.1186/s13052-017-0373-9 · 2017 · External reference

Comorbidity of Type 1 diabetes and juvenile idiopathic arthritis

10.1016/j.jpeds.2014.12.026 · 2015 · External reference

Increased mortality in adults with a history of juvenile rheumatoid arthritis: a population-based study

10.1002/1529-0131(200103)44:3<523::aid-anr99>3.0.co;2-1 · 2001 · External reference

National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study

2003 · External reference

Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab

10.1136/annrheumdis-2013-204021 · 2015 · External reference

Impact of DMARD treatment and systemic inflammation on all-cause mortality in patients with rheumatoid arthritis and interstitial lung disease: a cohort study from the German RABBIT register

10.1136/rmdopen-2023-003789 · 2024 · External reference

Mortality trends among patients with rheumatoid arthritis in Western Australia

10.1007/s40744-023-00562-0 · 2023 · External reference

All-cause and cause-specific mortality in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: a nationwide registry study

10.1093/rheumatology/keac210 · 2022 · External reference

Long-term mortality in treated-to-target RA and UA: results of the BeSt and IMPROVED cohort

10.1136/ard-2023-224814 · 2024 · External reference

The Norwegian patient registry and the Norwegian registry for primary health care: research potential of two nationwide health-care registries

10.1177/1403494819859737 · 2020 · External reference

Unresolved reference

2004 · External reference

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

10.1016/0021-9681(87)90171-8 · 1987 · External reference

Charlson comorbidity index: ICD-9 update and ICD-10 translation

2019 · External reference

Prevalence of coeliac disease in patients with rheumatoid arthritis and juvenile idiopathic arthritis: a systematic review and meta-analysis

10.55563/clinexprheumatol/b92b8a · 2024 · External reference

Juvenile idiopathic arthritis, uveitis and multiple sclerosis: description of two patients and literature review

10.3390/biomedicines10082041 · 2022 · External reference

Global burden of cardiovascular diseases and risks collaboration, 1990-2021

10.1016/j.jacc.2022.11.001 · 2022 · External reference

Chronic kidney disease and mortality risk: a systematic review

10.1681/asn.2005101085 · 2006 · External reference

Diabetes mellitus, fasting glucose, and risk of cause-specific death

10.1056/nejmoa1008862 · 2011 · External reference

Association between celiac disease and mortality risk in a Swedish population

10.1001/jama.2020.1943 · 2020 · External reference

The mortality rate and causes of death among juvenile idiopathic arthritis patients in Finland

2019 · External reference

Paediatric-onset immune-mediated inflammatory disease is associated with an increased mortality risk-A nationwide study

10.1111/apt.17994 · 2024 · External reference

Treatment response to tumor necrosis factor inhibitors and methotrexate monotherapy in adults with juvenile idiopathic arthritis: data from NOR-DMARD

10.3899/jrheum.220645 · 2023 · External reference

Effectiveness and safety of TNF inhibitors in adults with juvenile idiopathic arthritis

10.1136/rmdopen-2016-000273 · 2016 · External reference

Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis

10.1136/annrheumdis-2014-206034 · 2016 · External reference

Prevalence of and factors associated to chronic kidney disease and hypertension in a cohort of children with juvenile idiopathic arthritis

10.1007/s00431-020-03792-4 · 2021 · External reference

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome

10.1136/annrheumdis-2021-221733 · 2022 · External reference

EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update

10.1136/annrheumdis-2016-209775 · 2017 · External reference

Feasibility of cardiovascular disease risk assessments in rheumatology outpatient clinics: experiences from the nationwide NOCAR project

10.1136/rmdopen-2018-000737 · 2018 · External reference

Incidence and genetic risk of juvenile idiopathic arthritis in norway by latitude

10.1002/art.43040 · 2025 · External reference

Nordic health registry-based research: a review of health care systems and key registries

10.2147/clep.s314959 · 2021 · External reference